CRNX Annual Non Current Assets
$61.20 M
+$54.21 M+775.29%
31 December 2023
Summary:
As of January 22, 2025, CRNX annual long term assets is $61.20 million, with the most recent change of +$54.21 million (+775.29%) on December 31, 2023. During the last 3 years, it has risen by +$55.25 million (+928.05%). CRNX annual non current assets is now at all-time high.CRNX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Quarterly Non Current Assets
$59.79 M
-$972.00 K-1.60%
30 September 2024
Summary:
As of January 22, 2025, CRNX quarterly long term assets is $59.79 million, with the most recent change of -$972.00 thousand (-1.60%) on September 30, 2024. Over the past year, it has dropped by -$5.99 million (-9.11%). CRNX quarterly non current assets is now -9.11% below its all-time high of $65.78 million, reached on September 30, 2023.CRNX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +775.3% | -9.1% |
3 y3 years | +928.0% | -9.1% |
5 y5 years | +1193.3% | -9.1% |
CRNX Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +872.2% | -9.1% | +1087.0% |
5 y | 5-year | at high | +928.0% | -9.1% | +1087.0% |
alltime | all time | at high | >+9999.0% | -9.1% | >+9999.0% |
Crinetics Pharmaceuticals Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $59.79 M(-1.6%) |
June 2024 | - | $60.76 M(-0.3%) |
Mar 2024 | - | $60.92 M(-0.4%) |
Dec 2023 | $558.55 M(+61.8%) | $61.20 M(-7.0%) |
Sept 2023 | - | $65.78 M(+679.1%) |
June 2023 | - | $8.44 M(-1.9%) |
Mar 2023 | - | $8.61 M(+23.1%) |
Dec 2022 | $345.18 M(+0.1%) | $6.99 M(+6.6%) |
Sept 2022 | - | $6.56 M(+20.4%) |
June 2022 | - | $5.45 M(+8.2%) |
Mar 2022 | - | $5.04 M(-20.0%) |
Dec 2021 | $344.72 M | $6.29 M(+16.9%) |
Sept 2021 | - | $5.39 M(-3.4%) |
June 2021 | - | $5.57 M(-3.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $5.75 M(-3.5%) |
Dec 2020 | $177.49 M(+43.9%) | $5.95 M(-3.9%) |
Sept 2020 | - | $6.20 M(-4.9%) |
June 2020 | - | $6.51 M(-3.0%) |
Mar 2020 | - | $6.72 M(-4.6%) |
Dec 2019 | $123.34 M(-26.0%) | $7.04 M(-0.9%) |
Sept 2019 | - | $7.11 M(-3.9%) |
June 2019 | - | $7.39 M(-3.4%) |
Mar 2019 | - | $7.65 M(+61.6%) |
Dec 2018 | $166.68 M(+999.1%) | $4.73 M(-16.1%) |
Sept 2018 | - | $5.64 M(+18.6%) |
June 2018 | - | $4.76 M(+197.8%) |
Mar 2018 | - | $1.60 M(+269.1%) |
Dec 2017 | $15.16 M(+22.6%) | $433.00 K |
Dec 2016 | $12.37 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual non current assets year-on-year change?
- What is Crinetics Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly non current assets year-on-year change?
What is Crinetics Pharmaceuticals annual long term assets?
The current annual non current assets of CRNX is $61.20 M
What is the all time high annual non current assets for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual long term assets is $61.20 M
What is Crinetics Pharmaceuticals annual non current assets year-on-year change?
Over the past year, CRNX annual long term assets has changed by +$54.21 M (+775.29%)
What is Crinetics Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of CRNX is $59.79 M
What is the all time high quarterly non current assets for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly long term assets is $65.78 M
What is Crinetics Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, CRNX quarterly long term assets has changed by -$5.99 M (-9.11%)